Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2013, Article ID 343027, 5 pages
http://dx.doi.org/10.1155/2013/343027
Case Report

Resolution of Angina Pectoris and Improvement of the Coronary Flow Reserve after Ranolazine Treatment in a Woman with Isolated Impaired Coronary Microcirculation

1Cardioangiology with CCU, Department of Clinical and Experimental Medicine, Federico II University Hospital, 80131 Naples, Italy
2Laboratory of Echocardiography, Cardioangiology with CCU, Department of Clinical and Experimental Medicine, Federico II University Hospital, 80131 Naples, Italy

Received 11 January 2013; Accepted 14 February 2013

Academic Editors: R. Akdemir and H. Kataoka

Copyright © 2013 Alessandro Santoro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. U.S. Department of Health and Human Services, National Center for Health Statistics, Third National Health and Nutrition Examination Survey (NHANES III) 1988–1994 (CD-ROM), Series 11, No. 1, Centers for Disease Control and Prevention, Hyattsville, Md, USA, 1997.
  2. P. W. Serruys, F. Unger, J. E. Sousa et al., “Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease,” The New England Journal of Medicine, vol. 344, no. 15, pp. 1117–1124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. B. R. Chaitman, C. J. Pepine, J. O. Parker et al., “Effects of ranolazine with atenolol, amlodipine or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina. A randomized controlled trial,” Journal of the American Medical Association, vol. 291, no. 3, pp. 309–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. P. H. Stone, N. A. Gratsiansky, A. Blokhin, I. Z. Huang, and L. Meng, “Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial,” Journal of the American College of Cardiology, vol. 48, no. 3, pp. 566–575, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. B. M. Scirica, D. A. Morrow, H. Hod et al., “Effect of ranolazine, an antianginal agent with novel electrophysiological properties, on the incidence of arrhythmias in patients with non-ST-segment-elevation acute coronary syndrome: results from the metabolic efficiency with ranolazine for less ischemia in non-ST-elevation acute coronary syndrome-thrombolysis in myocardial infarction 36 (MERLIN-TIMI 36) randomized controlled trial,” Circulation, vol. 116, no. 15, pp. 1647–1652, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Sicari, P. Nihoyannopoulos, A. Evangelista et al., “Stress echocardiography expert consensus statement—executive summary: European Association of Echocardiography (EAE) (a registered branch of the ESC),” European Heart Journal, vol. 30, no. 3, pp. 278–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. B. D. Johnson, L. J. Shaw, S. D. Buchthal et al., “Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE),” Circulation, vol. 109, no. 24, pp. 2993–2999, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Belardinelli, J. C. Shryock, and H. Fraser, “Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine,” Heart, vol. 92, supplement 4, pp. iv6–iv14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. P. K. Mehta, P. Goykhman, L. E. J. Thomson et al., “Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease,” JACC Cardiovascular Imaging, vol. 4, no. 5, pp. 514–522, 2011. View at Publisher · View at Google Scholar · View at Scopus